Pulmonary Hypertension
2 competing products in clinical development for Pulmonary Hypertension.
Pipeline by Phase
Pre-clinical1
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| TX000045- Dose A + TX000045- Dose B + Placebo | Tectonic Therapeutic | Phase 2 | Recruiting | 36 |
| Regadenoson | Astellas Pharma | Pre-clinical | Terminated | 18 |